71083-18-6 Usage
Uses
Used in Pharmaceutical Industry:
7-(trifluoromethyl)quinoline-3-carboxylic acid ethyl ester is used as a chemical building block for the synthesis of bioactive molecules and potential drug candidates. Its unique structure and functional groups make it a valuable intermediate in the development of new pharmaceutical compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 7-(trifluoromethyl)quinoline-3-carboxylic acid ethyl ester is used as a key intermediate for the preparation of a variety of complex organic molecules. Its reactivity and functional groups allow for the creation of diverse chemical entities.
Used in Medicinal Chemistry:
7-(trifluoromethyl)quinoline-3-carboxylic acid ethyl ester is utilized as a starting material in medicinal chemistry for the design and synthesis of new drugs. The trifluoromethyl group in its structure can influence the pharmacokinetic and pharmacodynamic properties of the resulting compounds, making it a valuable tool in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 71083-18-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,0,8 and 3 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 71083-18:
(7*7)+(6*1)+(5*0)+(4*8)+(3*3)+(2*1)+(1*8)=106
106 % 10 = 6
So 71083-18-6 is a valid CAS Registry Number.
71083-18-6Relevant academic research and scientific papers
A one-step synthesis of 2,4-unsubstituted quinoline-3-carboxylic acid esters from o -nitrobenzaldehydes
Venkatesan, Hariharan,Hocutt, Frances M.,Jones, Todd K.,Rabinowitz, Michael H.
supporting information; experimental part, p. 3488 - 3491 (2010/08/03)
A straightforward and efficient one-step procedure for the synthesis of 2,4-unsubstituted quinoline-3-carboxylic acid ethyl esters is described. The simple reductive cyclization is carried out by treating various substituted o-nitrobenzaldehydes with inex
SUBSTITUTED N-BICYCLICALKYL BICYCLIC CARBOXYAMIDE COMPOUNDS
-
Page/Page column 50, (2008/12/07)
This invention provides compounds of the formula (I): and their use for the treatment of disease conditions caused by overactivation of the VR1 receptor such as pain, or the like in mammal. The invention also provides pharmaceutical compositions comprising the above compounds.
